Y-90 MICROSPHERE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) PATIENT-DERIVED TUMOROIDS AND CELL LINES REVEALS HETEROGENEITY OF RESPONSE

被引：0

作者：

Malone, Christopher ^{[1
]}

Zheleznyak, Alexander ^{[1
]}

Sonnek, Naomi ^{[1
]}

Sullentrup, Robert ^{[1
]}

Blanc, Valerie ^{[1
]}

Strnad, Benjamin S. ^{[1
]}

Nix, Darren ^{[1
]}

Liu, Xiuli ^{[1
]}

Cliften, Paul ^{[1
]}

Weber, Jason ^{[1
]}

Fields, Ryan ^{[1
]}

Ciorba, Matthew ^{[1
]}

Davidson, Nicholas ^{[2
,3
]}

机构：

[1] Washington Univ, St Louis, MO USA

[2] Washington Univ, Sch Med, Dept Med, St Louis, MO USA

[3] Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO USA

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4156-A

引用

页码：S1911 / S1911

页数：1

共 50 条

[31] Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma
Kamel, Ihab R.
Reyes, Diane K.
Liapi, Eleni
Bluemke, David A.
Geschwind, Jean-Francois H.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2007, 18 (01) : 49 - 56
[32] Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models
Hong, Baoan
Yang, Yong
Guo, Sheng
Duoerkun, Shayiremu
Deng, Xiaohu
Chen, Dawei
Yu, Shijun
Qian, Wubin
Li, Qixiang
Li, Qing
Gong, Kan
Zhang, Ning
ONCOTARGET, 2017, 8 (30) : 49839 - 49850
[33] PET/CT-based Y-90 microsphere dosimetry to predict contralateral lobe hypertrophy after unilobar radioembolization in treatment-naive hepatocellular carcinoma
Kang, Y.
Paeng, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S661 - S662
[34] LIPOPHILIC STATIN INCREASES SENSITIVITY FOR LENVATINIB BY SUPPRESSING YAP/TAZ IN HEPATOCELLULAR CARCINOMA CELL LINES AND PATIENT-DERIVED ORGANOIDS
Lee, Jae Seung
Cho, Kyung Joo
Park, Hye Jung
Lee, Hye Won
Kim, Mi Na
Kim, Beom Kyung
Kim, Do Young
Ahn, Sang Hoon
Park, Jun Yong
HEPATOLOGY, 2024, 80
[35] The effect of a targeted poxvirus (JX-594) on Hepatocellular Carcinoma (HCC) derived cell lines
Jebar, A.
Peckham-Cooper, A.
Errington-Mais, F.
Melcher, A.
Griffin, S.
HUMAN GENE THERAPY, 2014, 25 (12) : A28 - A28
[36] A patient-derived hepatocellular carcinoma multicellular spheroid platform harnessing autologous patient serum to model the tumor microenvironment and treatment response
Crouchet, Emilie
Almeida, Nuno
Durand, Sarah C.
Parnot, Marie
Oudot, Marine A.
Giannone, Fabio
Gadenne, Cloe
Cherradi, Sara
Roehlen, Natascha
Saviano, Antonio
Felli, Emanuele Emanuele
Pessaux, Patrick
Chayama, Kazuaki
Duong, Hong Tuan F.
Baumert, Thomas F.
Schuster, Catherine
CANCER RESEARCH, 2024, 84 (06)
[37] SURVIVAL AND TOLERABILITY FOLLOWING 90Y-RESIN MICROSPHERE RADIOEMBOLISATION IN PATIENTS WITH UNRESECTABLE BCLC STAGE 'C' HEPATOCELLULAR CARCINOMA (HCC)
Sangro, B.
Ettorre, G. M.
Cianni, R. C.
Gasparini, D.
Golfieri, R.
Ezzidin, S.
Kolligs, F.
Izzo, F.
JOURNAL OF HEPATOLOGY, 2011, 54 : S262 - S263
[38] A PHASE-I DOSE ESCALATION TRIAL OF Y-90 MICROSPHERES IN THE TREATMENT OF PRIMARY HEPATOCELLULAR-CARCINOMA
SHEPHERD, FA
ROTSTEIN, LE
HOULE, S
YIP, TCK
PAUL, K
SNIDERMAN, KW
CANCER, 1992, 70 (09) : 2250 - 2254
[39] Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinoma
Malone, Christopher D.
Egbulefu, Christopher
Zheleznyak, Alexander
Polina, Jahnavi
Karmakar, Partha
Black, Kvar
Shokeen, Monica
Achilefu, Samuel
SCIENTIFIC REPORTS, 2022, 12 (01)
[40] Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma
Yeonhwa Song
Jin-Sun Kim
Se-Hyuk Kim
Yoon Kyung Park
Eunsil Yu
Ki-Hun Kim
Eul-Ju Seo
Heung-Bum Oh
Han Chu Lee
Kang Mo Kim
Haeng Ran Seo
Journal of Experimental & Clinical Cancer Research, 37

← 1 2 3 4 5 →